nefazodone has been researched along with Anxiety in 7 studies
nefazodone: may be useful as an opiate adjunct
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore further the role of serotonin (5-HT) in anxiety, the effects of the 5-HT reuptake inhibitor and 5-HT2A receptor antagonist nefazodone (NF) were measured in two human models of anxiety." | 9.09 | Opposite effects of nefazodone in two human models of anxiety. ( Graeff, FG; Guimarães, FS; Hetem, LA; Silva, M, 2001) |
| "Thus, nefazodone therapy was associated with improvement in mood/anxiety and alcohol use, which seem to be independent of each other in this patient sample." | 5.10 | Open-label nefazodone in patients with a major depressive episode and alcohol dependence. ( Bobadilla, L; Brown, ES; Dhillon, H; Frol, A; Nejtek, VA; Perantie, D, 2003) |
| "To explore further the role of serotonin (5-HT) in anxiety, the effects of the 5-HT reuptake inhibitor and 5-HT2A receptor antagonist nefazodone (NF) were measured in two human models of anxiety." | 5.09 | Opposite effects of nefazodone in two human models of anxiety. ( Graeff, FG; Guimarães, FS; Hetem, LA; Silva, M, 2001) |
| "Lifetime psychiatric illness is also common in women with PMDD, and although mood disorders predominate, past histories of anxiety disorders are also common, further suggesting an association between PMDD and anxiety disorders." | 2.40 | Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders? ( Yonkers, KA, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Núñez, MJ | 1 |
| Rivas, M | 1 |
| Riveiro, P | 1 |
| Suárez, J | 1 |
| Balboa, J | 1 |
| Núñez, LA | 1 |
| Rey-Méndez, M | 1 |
| Freire-Garabal, M | 1 |
| Brown, ES | 1 |
| Bobadilla, L | 1 |
| Nejtek, VA | 1 |
| Perantie, D | 1 |
| Dhillon, H | 1 |
| Frol, A | 1 |
| Suri, R | 1 |
| Burt, VK | 1 |
| Altshuler, LL | 1 |
| Ketter, TA | 1 |
| Callahan, AM | 1 |
| Post, R | 1 |
| Yonkers, KA | 1 |
| Silva, M | 1 |
| Hetem, LA | 1 |
| Guimarães, FS | 1 |
| Graeff, FG | 1 |
| Ströhle, A | 1 |
| Ehrenthal, HD | 1 |
1 review available for nefazodone and Anxiety
| Article | Year |
|---|---|
Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?
Topics: 1-Naphthylamine; Adult; Age of Onset; Anxiety; Anxiety Disorders; Buspirone; Carbon Dioxide; Comorbi | 1997 |
2 trials available for nefazodone and Anxiety
| Article | Year |
|---|---|
Open-label nefazodone in patients with a major depressive episode and alcohol dependence.
Topics: Adult; Affect; Alcoholism; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; D | 2003 |
Opposite effects of nefazodone in two human models of anxiety.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety; Conditioning, Psycho | 2001 |
4 other studies available for nefazodone and Anxiety
| Article | Year |
|---|---|
Effects of nefazodone on voluntary ethanol consumption induced by isolation stress in young and aged rats.
Topics: Aging; Alcohol Drinking; Animals; Antidepressive Agents, Second-Generation; Anxiety; Corticosterone; | 2002 |
Nefazodone for the treatment of postpartum depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Controlled Clinical Trials as Topic; Depre | 2005 |
Nefazodone relief of alprazolam interdose dysphoria: a potential therapeutic benefit of 3A3/4 inhibition.
Topics: Alprazolam; Antidepressive Agents, Second-Generation; Anxiety; Cytochrome P-450 Enzyme Inhibitors; D | 1996 |
Nefazodone may increase anxiety in panic disorder.
Topics: Adult; Anxiety; Humans; Male; Panic Disorder; Piperazines; Triazoles | 2002 |